Skip to content

Comprehensive Cardiac CT Versus Exercise Testing in Suspected Coronary Artery Disease (2)

Comprehensive Cardiac CT Versus Exercise Testing in Suspected Coronary Artery Disease (2)

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02291484
Acronym
CRESCENT2
Enrollment
250
Registered
2014-11-14
Start date
2013-08-31
Completion date
2016-05-31
Last updated
2016-08-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stable Angina Pectoris, Coronary Artery Disease

Keywords

Computed tomography, Coronary angiography, Coronary artery disease, Perfusion imaging, Comparative effectiveness, Randomized controlled trial, Cost-effectiveness

Brief summary

Multi-center, randomized-controlled trial comparing a comprehensive cardiac CT protocol with standard stress testing in patients with stable chest pain complaints.

Detailed description

Rationale: CT calcium and coronary lumen imaging allow efficient exclusion of coronary artery disease (CAD), but cannot assess the hemodynamic significance of obstructive findings. Addition of stress myocardial perfusion imaging, which assesses the functional relevance of coronary narrowing, completes the non-invasive cardiac evaluation. Hypothesis: A comprehensive cardiac CT examination will allow fast, accurate and complete evaluation of suspected CAD. Objective: evaluate the effectiveness and efficiency of comprehensive cardiac CT workup of suspected CAD. Study design: Open-labelled, randomized-controlled, clinical efficiency trial, with an intention-to-diagnose approach, between CT-guided management and the current standard of care (based on functional testing of provocable myocardial ischemia) in patients with suspected CAD. Study population: 250 patients (\>18 yrs) with stable chest complaints, a \>10% pre-test probability of CAD, and referred for evaluation of possible CAD. Intervention: Instead of the usual diagnostic approach, patients in the intervention group will undergo in sequence the following CT examinations: coronary calcium scan, coronary CT angiography and CT myocardial perfusion imaging, with completion dependent on results. Findings on CT will direct further management. Main study parameters/endpoints: Primary: Rate of negative invasive angiograms (as percentage of total population) Secondary: Diagnostic yield, chest complaints, quality of life, diagnostic and therapeutic procedures, overall costs and adverse events at 6 months.

Interventions

CT-guided management

Sponsors

Erasmus Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Men and women aged \>18 years. * Chest pain symptoms suspicious of coronary heart disease. * Pre-test probability of coronary artery disease \>10%

Exclusion criteria

* History of CAD: prior myocardial infarction or revascularization procedure * Contra-indication to radiation exposure (CT/SPECT): pregnancy * Contra-indication to iodine contrast media: renal failure, iodine allergy * Contra-indications to adenosine * Inability or unwillingness to provide informed consent.

Design outcomes

Primary

MeasureTime frameDescription
Rate of negative invasive angiograms (as percentage of total population)6 monthsNumber of performed invasive angiograms with no CAD requiring intervention

Secondary

MeasureTime frameDescription
Quality of life6 monthsQuestionnaire based quality of life score
Major adverse event rate6 monthsDeath, myocardial infarction, unstable angina, urgent revascularizations, CVA
Chest pain complaints6 monthsProportion of patients experiencing symptoms of chest pain
Number of diagnostic and therapeutic procedures6 monthsNumber of diagnostic and therapeutic procedures
Medical expenses6 monthsAll medical expenses related to the diagnosis and treatment of suspected CAD
Radiation exposure6 monthsCumulative radiation dose from diagnostic and therapeutic interventions

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 8, 2026